✦ LIBER ✦

Emerging new therapies for chemotherapy—resistant cancer using adenoviral vectors

✍ Scribed by John Nemunaitis; Casey Cunningham

Book ID: 117764478
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 159 KB
Volume: 5
Category: Article
ISSN: 1368-7646
DOI: 10.1016/s1368-7646(02)00048-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for cancer gene therapy using

Strategies for cancer gene therapy using adenoviral vectors

✍ Descamps, V.; Duffour, M. -T.; Mathieu, M. -C.; Fernandez, N.; Cordier, L.; Abin 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 961 KB

Adenoviral vector–mediated gene transfer

Adenoviral vector–mediated gene transfer of IL-13Rα2 chain followed by IL-13 cytotoxin treatment offers potent targeted therapy for cytotoxin-resistant cancers

✍ Makoto Saito; Takashi Murata; Ken Watanabe; Koji Kawakami; Motoyoshi Suzuki; Tak 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 404 KB

## Abstract Previous studies demonstrated that IL‐13Rα2 chain–overexpressing cancer cells were highly sensitive to IL‐13 cytotoxin (IL13‐PE38QQR) and could be targeted by cytotoxin treatment. However, the majority of human tumors do not express high levels of IL‐13Rα2 chain. To expand the IL‐13 cyt

A nonreplicating adenoviral vector that

A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer : Safety, efficacy, and biologic activity of a novel gene-therapy approach

✍ Massimo Cristofanilli; Savitri Krishnamurthy; Laura Guerra; Kristine Broglio; Ba 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB 👁 1 views

New recombinant mycobacteria and plasmid

New recombinant mycobacteria and plasmids; recombinant Mycobacterium bovis-BCG using Escherichia coli-BCG shuttle vector plasmid, for application as a recombinant vaccine, and for cancer therapy : Beth.-Israel Hosp.; Whitehead Inst. Biomed. Res. World 9503 418; 2 February 1995

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Genomic DNA encoding a tumor rejection a

Genomic DNA encoding a tumor rejection antigen precursor; recombinant tumor rejection antigen and tumor rejection antigen production by vector expression and DNA probe for use in disease diagnosis, therapy and recombinant vaccine : Ludwig Inst. Cancer Res. Brichard V; Coulie P; Boon-Falleur T; De Plaen E; Traversari C; Wolfel T: New York, USA. WO 9601-557: 10.01.95-95US-370319 (25.01.96) (08.07.94-94US-272351) 27.06.95 as 95WO-US08153. 96-097390/10 World 9601 557; 25 January 1996

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 159 KB